Yin et al. have demonstrated that TGF-β, released during bone resorption, enhances the expression of PTHrP by breast cancer cells, which in turn increases RANKL expression by osteoblasts, driving further osteoclastogenesis and bone destruction (Yin et al., 1999). Here, TGFB1 is linked to breast carcinoma.